Zenpep FDA Approval History
FDA Approved: Yes (First approved August 27, 2009)
Brand name: Zenpep
Generic name: pancrelipase
Dosage form: Capsules
Previous Name: Zentase
Company: Allergan plc
Treatment for: Pancreatic Exocrine Dysfunction
Zenpep (pancrelipase) is a combination of porcine-derived lipases, proteases, and amylases indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis, or other conditions.
Development Timeline for Zenpep
|Aug 28, 2009||Approval Eurand Granted FDA Approval for Zenpep|
|Jun 19, 2008||Eurand Receives Approvable Letter From FDA for EUR-1008 (Zentase)|
|Feb 21, 2008||Eurand Granted Priority Review for Zentase NDA|
|Dec 20, 2007||Eurand Completes New Drug Application for Zentase|
|Jun 12, 2007||Eurand Files NDA for Zentase for Exocrine Pancreatic Insufficiency|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.